A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis
Alexander Teml(Statistics Austria), Walter Reinisch(Medical University of Vienna), Martina Mantl, Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Harald Vogelsang(Medical University of Vienna), Elke Schaeffeler(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Clemens Dejaco, Marieluise Harrer, Barbara Schneider(Altonaer Kinderkrankenhaus), Wolfgang Miehsler(Medical University of Vienna)
Cited by 23
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
|Gastroenterology|2013|938
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718